Purpose

This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 female participants recruited from migraine treatment facilities and support groups in the US.

Conditions

Eligibility

Eligible Ages
Between 18 Years and 55 Years
Eligible Genders
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female by birth - Diagnosis of migraine with or without aura, based on ICHD3 criteria - 6-14 migraine days/month. - ≥ one year history of migraines starting before the age of 50. - ≥ 18 years old or ≤ 55 Years old - Willing to attend follow-up sessions. - Willing to practice TM twice a day for 20 minutes. - Agreeable to participate and to be randomized to either group. - Fluent in English. Willing to continue same medication without any additional medicine In good general health with no other diseases expected to interfere with the study.

Exclusion Criteria

  • > 55 years old or < 18 Years old - Already practicing Transcendental Meditation. - Pre-diagnosed major systemic illness or unstable medical/psychiatric condition (eg, suicide risk) requiring immediate treatment or that could compromise protocol adherence - Medication overuse headache (MOH) - Current/planned pregnancy or breastfeeding - New prophylactic migraine medicine started within 4 weeks of the screening visit - Unwilling to maintain stable migraine medication dosages - Failure to complete baseline headache logs.

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Non-Randomized
Intervention Model
Single Group Assignment
Intervention Model Description
It is a pilot study investigating the impact of Transcendental Meditation on migraine as a basis for a larger randomized control study.
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Exploring the Effect of the Transcendental Meditation® Technique on Migraine
  • Behavioral: Meditation
    The objective of this study is to assess the safety, feasibility, and effects of the practice of the Transcendental Meditation technique in adults with migraines. This study will involve 30 male and female participants recruited from migraine treatment facilities and migraine support groups in the US. The study will span three months, with all participants practicing Transcendental Meditation (TM) while continuing their usual lifestyle and medication regimen. Pre-data will be collected through symptom analysis, headache patterns, and evaluation questionnaires. All potential subjects will use a migraine App for 30 days prior to inclusion in the study, both as a means of assessing migraine status and of ability to adhere to study protocols during the study. In addition, all subjects will take the PHQ-9 to screen for levels of depression that might impair participation in the study. All the subjects will receive TM instruction, followed by bi-weekly

Recruiting Locations

Georgetown Headache Center and DC area
Washington, District of Columbia 20036
Contact:
Dr. Jamie Grant, EdD
831-325--7637
jgrant@tm.org

More Details

Status
Recruiting
Sponsor
Maharishi International University

Study Contact

Asha Sharma, MS
5158092899
asharma@miu.edu

Detailed Description

The objective of this study is to assess the safety, feasibility, and effects of the practice of the Transcendental Meditation technique in adults with migraines. This study will involve 30 female participants recruited from migraine treatment facilities and migraine support groups in the US. The study will span three months, with all participants practicing Transcendental Meditation (TM) while continuing their usual lifestyle and medication regimen. Pre-data will be collected through symptom analysis, headache patterns, and evaluation questionnaires. All potential subjects will keep a daily migraine diary for 30 days before inclusion in the study, both to assess migraine status and to adhere to study protocols during the study. All the subjects will receive TM instruction, followed by bi-weekly group meetings and one-on-one sessions for 3 months to monitor progress and ensure correct practice.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.